Ignite Creation Date:
2024-05-06 @ 2:02 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04197986
Status:
TERMINATED
Last Update Posted:
2024-03-13
First Post:
2019-12-02
Brief Title:
Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations
Sponsor:
Organization:
QED Therapeutics Inc